Cas 858102-54-2,3-cyclohexyl-2-[(methanesulfonyliminomethylsulfanylmethyl)amino]propionic acid

858102-54-2

Post Buying Request

Basic information

Product Name: 3-cyclohexyl-2-[(methanesulfonyliminomethylsulfanylmethyl)amino]propionic acid
Synonyms: 3-cyclohexyl-2-[(methanesulfonyliminomethylsulfanylmethyl)amino]propionic acid
CAS NO:858102-54-2
Molecular Formula:
Molecular Weight: 322.45
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-cyclohexyl-2-[(methanesulfonyliminomethylsulfanylmethyl)amino]propionic acid(CAS DataBase Reference)
NIST Chemistry Reference: 3-cyclohexyl-2-[(methanesulfonyliminomethylsulfanylmethyl)amino]propionic acid(858102-54-2)
EPA Substance Registry System: 3-cyclohexyl-2-[(methanesulfonyliminomethylsulfanylmethyl)amino]propionic acid(858102-54-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 858102-54-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

858102-54-2 Suppliers

Recommended suppliers

858102-54-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 858102-54-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,1,0 and 2 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 858102-54:
(8*8)+(7*5)+(6*8)+(5*1)+(4*0)+(3*2)+(2*5)+(1*4)=172
172 % 10 = 2
So 858102-54-2 is a valid CAS Registry Number.

858102-54-2Upstream product

858102-54-2Downstream Products

858102-54-2Relevant academic research and scientific papers

AMIDINO COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page/Page column 32-33, (2010/02/12)

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 858102-54-2